WAM
SXTPW icon

Warberg Asset Management’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Warberg Asset Management’s Portfolio SXTPW Stock Details SXTPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,515
Closed -$1.51K – 227
2024
Q3 		$1.51K Hold
29,515
– – ﹤0.01% 195
2024
Q2 		$2.36K Hold
29,515
– – ﹤0.01% 203
2024
Q1 		$2.24K Hold
29,515
– – ﹤0.01% 193
2023
Q4 		$2.07K Hold
29,515
– – ﹤0.01% 202
2023
Q3 		$10.3K Buy
+29,515
New +$12.7K ﹤0.01% 174

Other funds holding SXTPW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's SXTPW Position: Q4 2024 in Review

Warberg Asset Management sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q4 2024, closing a stake of 29,515 shares — an estimated $1.51K sold.

Warberg Asset Management first reported a position in SXTPW in Q3 2023 and held it in 5 quarters. The position peaked at $10.3K in Q3 2023. 7 funds tracked by Wall St. Rank hold SXTPW as of Q4 2024.

  • Warberg Asset Management reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q4 2024 after selling out during the quarter.
  • Warberg Asset Management sold 29,515 60 Degrees Pharmaceuticals Warrant shares in Q4 2024, an estimated $1.51K.
  • Warberg Asset Management first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and held it in 5 quarters.
  • Warberg Asset Management's 60 Degrees Pharmaceuticals Warrant position peaked at $10.3K in Q3 2023.
  • 7 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q4 2024.

Based on Warberg Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.